Rapid Micro Biosystems, Inc. (NASDAQ:RPID) CEO Robert G. Jr. Spignesi Sells 10,824 Shares

Rapid Micro Biosystems, Inc. (NASDAQ:RPID - Get Free Report) CEO Robert G. Jr. Spignesi sold 10,824 shares of the company's stock in a transaction dated Tuesday, July 8th. The shares were sold at an average price of $3.51, for a total transaction of $37,992.24. Following the sale, the chief executive officer owned 886,686 shares in the company, valued at $3,112,267.86. This represents a 1.21% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Rapid Micro Biosystems Price Performance

Shares of NASDAQ RPID traded down $0.01 during mid-day trading on Friday, hitting $3.36. 58,625 shares of the company's stock traded hands, compared to its average volume of 197,773. The company's 50-day moving average is $3.31 and its two-hundred day moving average is $2.59. The company has a market capitalization of $147.28 million, a P/E ratio of -3.26 and a beta of 1.32. Rapid Micro Biosystems, Inc. has a 1 year low of $0.64 and a 1 year high of $4.04.

Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) last announced its earnings results on Friday, May 9th. The company reported ($0.26) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $0.01. The firm had revenue of $7.21 million for the quarter, compared to analysts' expectations of $6.63 million. Rapid Micro Biosystems had a negative net margin of 151.22% and a negative return on equity of 56.07%. Equities analysts anticipate that Rapid Micro Biosystems, Inc. will post -1.1 EPS for the current fiscal year.

Hedge Funds Weigh In On Rapid Micro Biosystems

Hedge funds have recently added to or reduced their stakes in the company. American Century Companies Inc. bought a new position in Rapid Micro Biosystems during the 1st quarter valued at about $31,000. Legato Capital Management LLC bought a new position in Rapid Micro Biosystems during the 1st quarter valued at about $41,000. Millennium Management LLC grew its holdings in Rapid Micro Biosystems by 17.6% during the 4th quarter. Millennium Management LLC now owns 61,375 shares of the company's stock valued at $55,000 after purchasing an additional 9,191 shares during the last quarter. Citadel Advisors LLC bought a new position in Rapid Micro Biosystems during the 4th quarter valued at about $65,000. Finally, Renaissance Technologies LLC grew its holdings in Rapid Micro Biosystems by 122.9% during the 4th quarter. Renaissance Technologies LLC now owns 183,087 shares of the company's stock valued at $165,000 after purchasing an additional 100,942 shares during the last quarter. 52.60% of the stock is currently owned by institutional investors.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.